Wed. Sep 20th, 2023
    Abdominal Aortic Aneurysm Landscape and Market Forecast–2035

    DelveInsight’s report provides a comprehensive analysis of the Abdominal Aortic Aneurysm (AAA) competitive landscape and market forecast until 2035. The report focuses on the market trends of AAA in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

    Key Highlights for Abdominal Aortic Aneurysm:
    – Key companies in the AAA market include Jounce Therapeutics, GlaxoSmithKline, Kymab, Bristol-Myers Squibb, Xencor, and others.
    – Key therapies in the AAA market include GSK3359609, Vopratelimab, KY1044, and others.

    Abdominal Aortic Aneurysm Overview:
    Cancer immunotherapy (CI) has become a prominent pillar of cancer therapy, along with surgery, chemotherapy, radiation, and targeted therapy. One promising approach in CI involves antibodies to inhibitory immune checkpoint molecules. Inducible co-stimulator (ICOS) is a co-stimulatory molecule expressed by CD4 T cells that plays a role in proliferation and cytokine production. It is upregulated in activated T lymphocytes and can indicate the effectiveness of anti-CTLA4 therapies.

    ICOS has shown potential when combined with other immunotherapies, particularly CTLA4 blockade. The development of immuno-oncology therapies has transformed the landscape of cancer treatment and improved outcomes for many patients.

    The Report Covers the Abdominal Aortic Aneurysm Epidemiology Segmented by:
    – Prevalent cases
    – Incident cases
    – Treatment cases
    – Diagnosed cases

    Abdominal Aortic Aneurysm Market Outlook:
    The market outlook section provides a detailed understanding of the historical, current, and forecasted market trends. Factors such as unmet needs, drivers and barriers, and demand for improved technology are analyzed. The report evaluates each late-stage pipeline therapy in terms of its impact on the market, including the cost of treatment, mechanism of action, expected launch year, competition with other therapies, and more.

    According to DelveInsight, the AAA market is expected to generate USD 8,676 Million by 2035, with a significant CAGR during the forecast period.

    Key Companies Working in the Abdominal Aortic Aneurysm Market:
    – Jounce Therapeutics
    – GlaxoSmithKline
    – Kymab
    – Bristol-Myers Squibb
    – Xencor
    – And many others

    Abdominal Aortic Aneurysm Therapies Covered and Analyzed in the Report:
    – GSK3359609
    – Vopratelimab
    – KY1044
    – BMS-98622
    – XmAb23104
    – And many others

    For more information, please refer to the original article.

    – DelveInsight